DSE : CENTRALPHL
Central Pharmaceuticals Ltd. — Financial statements
Pharmaceutical Preparations · Bangladesh
Last price 8.3 BDT (At close: Oct 29, 2026) · Market cap 994.35M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Technical report: trend, RSI, support and resistance, charts
Financial statements
Central Pharmaceuticals Ltd. (CENTRALPHL) reported revenue of 36.10M BDT (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in BDT.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 36.10M | 33.06M | 29.60M | 29.33M | 26.00M | 148.15M |
| Cost of Revenue | 47.52M | 44.19M | 50.21M | 58.36M | 63.58M | 118.89M |
| Gross Profit | -11.43M | -11.13M | -20.61M | -29.03M | -37.58M | 29.27M |
| Selling, General & Admin | 11.85M | 11.57M | 16.65M | 18.83M | 15.77M | 22.45M |
| Other Operating Expenses | 444.10K | |||||
| Operating Expenses | 11.85M | 11.57M | 17.09M | 18.83M | 15.77M | 22.45M |
| Operating Income | -23.27M | -22.70M | -37.70M | -47.86M | -53.35M | 6.82M |
| Interest Expense | -17.36M | -21.36M | ||||
| Interest & Investment Income | 6.49K | 6.49K | 5.88K | 4.48K | 4.61K | 5.78K |
| Other Non Operating Income (Expenses) | -9.32K | -6.46K | -9.14K | -10.89K | -111.95K | -89.31K |
| EBT Excluding Unusual Items | -23.28M | -22.70M | -37.71M | -47.87M | -70.82M | -14.63M |
| Asset Writedown | -10.59M | |||||
| Pretax Income | -23.28M | -22.70M | -48.30M | -47.87M | -70.82M | -14.63M |
| Income Tax Expense | -1.60M | -716.16K | -5.88M | -3.91M | -2.57M | -6.16M |
| Net Income | -21.67M | -21.98M | -42.42M | -43.96M | -68.25M | -8.47M |
| Net Income to Common | -21.67M | -21.98M | -42.42M | -43.96M | -68.25M | -8.47M |
| Shares Outstanding (Basic) | 119.80M | 119.80M | 119.80M | 119.80M | 119.80M | 119.80M |
| Shares Outstanding (Diluted) | 119.80M | 119.80M | 119.80M | 119.80M | 119.80M | 119.80M |
| EPS (Basic) | -0.18 | -0.18 | -0.35 | -0.37 | -0.57 | -0.07 |
| EPS (Diluted) | -0.18 | -0.18 | -0.35 | -0.37 | -0.57 | -0.07 |
| Free Cash Flow | -24.35K | -518.47K | 2.97M | -325.98K | -1.12M | -4.78M |
| Free Cash Flow Per Share | 0.00 | -0.00 | 0.03 | -0.00 | -0.01 | -0.04 |
| Gross Margin | -31.66% | -33.66% | -69.62% | -98.99% | -144.57% | 19.75% |
| Operating Margin | -64.48% | -68.66% | -127.37% | -163.18% | -205.21% | 4.60% |
| Profit Margin | -60.04% | -66.49% | -143.31% | -149.88% | -262.51% | -5.72% |
| Free Cash Flow Margin | -0.07% | -1.57% | 10.02% | -1.11% | -4.31% | -3.22% |
| EBITDA | 2.83M | -1.08M | -24.25M | -21.11M | -23.59M | 39.71M |
| EBITDA Margin | 7.84% | -3.28% | -81.92% | -71.98% | -90.75% | 26.80% |
| D&A For EBITDA | 26.10M | 21.61M | 13.45M | 26.75M | 29.76M | 32.89M |
| EBIT | -23.27M | -22.70M | -37.70M | -47.86M | -53.35M | 6.82M |
| EBIT Margin | -64.48% | -68.66% | -127.37% | -163.18% | -205.21% | 4.60% |
Balance sheet
Fiscal year July - June; amounts in BDT.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.24M | 1.23M | 1.76M | 1.19M | 1.53M | 3.08M |
| Cash & Short-Term Investments | 1.24M | 1.23M | 1.76M | 1.19M | 1.53M | 3.08M |
| Receivables | 69.36M | 68.90M | 73.25M | 80.40M | 79.10M | 79.05M |
| Inventory | 16.25M | 22.00M | 17.79M | 21.60M | 39.70M | 61.40M |
| Other Current Assets | 287.06M | 287.06M | 287.06M | 287.06M | 286.82M | 287.06M |
| Total Current Assets | 373.91M | 379.20M | 379.87M | 390.24M | 407.16M | 430.58M |
| Property, Plant & Equipment | 1.04B | 1.05B | 1.06B | 877.48M | 904.23M | 933.99M |
| Other Intangible Assets | 77.00K | 83.24K | 92.49K | 102.77K | 114.19K | 126.88K |
| Other Long-Term Assets | 1.00 | 131.78K | ||||
| Total Assets | 1.41B | 1.43B | 1.44B | 1.27B | 1.31B | 1.36B |
| Accounts Payable | 27.77M | 19.25M | 8.46M | 5.29M | 1.50M | 648.37K |
| Accrued Expenses | 698.65K | 1.13M | 621.15K | 812.98K | 405.89K | 677.68K |
| Short-Term Debt | 300.00K | |||||
| Current Portion of Long-Term Debt | 36.50M | 36.50M | 36.50M | 36.50M | 36.50M | 27.37M |
| Current Income Taxes Payable | 280.74M | 280.58M | 280.38M | 280.20M | 280.02M | 279.87M |
| Other Current Liabilities | 6.82M | 6.82M | 6.82M | 6.82M | 6.82M | 6.83M |
| Total Current Liabilities | 352.53M | 344.27M | 333.07M | 329.62M | 325.25M | 315.39M |
| Long-Term Debt | 231.98M | 231.98M | 231.98M | 231.98M | 231.98M | 224.06M |
| Long-Term Deferred Tax Liabilities | 29.39M | 29.39M | 30.31M | 36.36M | 40.44M | 43.17M |
| Other Long-Term Liabilities | -21.67M | -2.00 | -1.00 | |||
| Total Liabilities | 592.22M | 605.64M | 595.36M | 597.95M | 597.67M | 582.62M |
| Common Stock | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B |
| Retained Earnings | -1.11B | -1.11B | -1.09B | -1.04B | -999.02M | -930.64M |
| Comprehensive Income & Other | 732.69M | 732.69M | 732.69M | 514.85M | 514.85M | 514.85M |
| Shareholders' Equity | 816.86M | 823.32M | 845.30M | 669.88M | 713.83M | 782.21M |
| Total Liabilities & Equity | 1.41B | 1.43B | 1.44B | 1.27B | 1.31B | 1.36B |
| Total Debt | 268.47M | 268.47M | 268.77M | 268.47M | 268.47M | 251.43M |
| Net Cash (Debt) | -267.23M | -267.24M | -267.01M | -267.28M | -266.94M | -248.36M |
| Net Cash Per Share | -2.23 | -2.23 | -2.23 | -2.23 | -2.23 | -2.07 |
| Filing Date Shares Outstanding | 119.80M | 119.80M | 119.80M | 119.80M | 119.80M | 119.80M |
| Total Common Shares Outstanding | 119.80M | 119.80M | 119.80M | 119.80M | 119.80M | 119.80M |
| Working Capital | 21.38M | 34.93M | 46.80M | 60.63M | 81.91M | 115.19M |
| Book Value Per Share | 6.82 | 6.87 | 7.06 | 5.59 | 5.96 | 6.53 |
| Tangible Book Value | 816.78M | 823.23M | 845.21M | 669.77M | 713.72M | 782.09M |
| Tangible Book Value Per Share | 6.82 | 6.87 | 7.06 | 5.59 | 5.96 | 6.53 |
| Land | 856.42M | 638.58M | ||||
| Buildings | 188.01M | 188.01M | ||||
| Machinery | 628.17M | 628.17M |
Cash flow statement
Fiscal year July - June; amounts in BDT.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -21.67M | -21.98M | -43.96M | -43.96M | -68.25M | -8.47M |
| Depreciation & Amortization | 36.19M | 21.61M | 13.45M | 26.75M | 29.76M | 32.89M |
| Other Amortization | 9.25K | 9.25K | 10.28K | 11.42K | 12.69K | |
| Asset Writedown & Restructuring Costs | 177.60K | |||||
| Other Operating Activities | -21.59M | -7.20M | 19.67M | 10.89K | 17.47M | 21.32M |
| Change in Accounts Receivable | 4.35M | 4.35M | 7.14M | -1.30M | -46.45K | -23.03M |
| Change in Inventory | -6.46M | -6.46M | 3.80M | 17.12M | 20.58M | -7.41M |
| Change in Accounts Payable | 10.43M | 10.43M | 4.21M | 3.79M | 850.81K | -1.39M |
| Change in Income Taxes | 198.35K | 198.35K | 4.25M | 175.97K | 155.99K | 888.91K |
| Change in Other Net Operating Assets | -568.56K | -568.56K | 261.21K | 1.16M | 1.07M | -5.95M |
| Operating Cash Flow | -24.35K | -518.47K | 2.97M | -325.98K | -1.12M | 1.80M |
| Capital Expenditures | -6.57M | |||||
| Investing Cash Flow | -6.57M | |||||
| Short-Term Debt Issued | 9.12M | |||||
| Long-Term Debt Issued | 7.92M | 25.21M | ||||
| Total Debt Issued | 17.04M | 25.21M | ||||
| Net Debt Issued (Repaid) | 17.04M | 25.21M | ||||
| Other Financing Activities | -1.42K | -6.46K | -9.14K | -10.89K | -17.47M | -21.45M |
| Financing Cash Flow | -1.42K | -6.46K | -9.14K | -10.89K | -426.94K | 3.76M |
| Net Cash Flow | -516.29K | -524.92K | 2.96M | -336.87K | -1.55M | -1.02M |
| Free Cash Flow | -24.35K | -518.47K | 2.97M | -325.98K | -1.12M | -4.78M |
| Free Cash Flow Margin | -0.07% | -1.57% | 10.02% | -1.11% | -4.31% | -3.22% |
| Free Cash Flow Per Share | 0.00 | -0.00 | 0.03 | -0.00 | -0.01 | -0.04 |
| Levered Free Cash Flow | 19.07M | 4.00M | 17.79M | 8.19M | -19.67M | |
| Unlevered Free Cash Flow | 19.07M | 4.00M | 17.79M | 19.04M | -6.32M | |
| Cash Interest Paid | 1.42K | 6.46K | 9.14K | 17.36M | 21.36M | |
| Cash Income Tax Paid | 26.46M | -1.95K | 1.76K | 352.19K | 111.17K | 5.95M |
| Change in Working Capital | 7.04M | 7.04M | 13.62M | 16.86M | 19.89M | -43.95M |
Ratios
Fiscal year July - June; amounts in BDT.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 994.35M | 1.25B | 2.17B | 1.49B | 1.57B | 1.58B |
| Enterprise Value | 1.26B | 1.51B | 2.45B | 1.75B | 1.82B | 1.80B |
| Last Close Price | 8.30 | 10.40 | 18.10 | 12.40 | 13.10 | 13.20 |
| PS Ratio | 27.55 | 37.69 | 73.25 | 50.65 | 60.37 | 10.67 |
| PB Ratio | 1.22 | 1.51 | 2.56 | 2.22 | 2.20 | 2.02 |
| P/TBV Ratio | 1.22 | 1.51 | 2.57 | 2.22 | 2.20 | 2.02 |
| P/FCF Ratio | 731.27 | |||||
| P/OCF Ratio | 731.27 | 880.40 | ||||
| EV/Sales Ratio | 34.95 | 45.77 | 82.90 | 59.75 | 69.92 | 12.17 |
| EV/EBITDA Ratio | 45.42 | |||||
| EV/EBIT Ratio | 264.59 | |||||
| EV/FCF Ratio | 827.53 | |||||
| Debt / Equity Ratio | 0.33 | 0.33 | 0.32 | 0.40 | 0.38 | 0.32 |
| Debt / EBITDA Ratio | 94.91 | 6.33 | ||||
| Debt / FCF Ratio | 90.64 | |||||
| Net Debt / Equity Ratio | 0.33 | 0.33 | 0.32 | 0.40 | 0.37 | 0.32 |
| Net Debt / EBITDA Ratio | 94.47 | -246.49 | -11.01 | -12.66 | -11.31 | 6.25 |
| Net Debt / FCF Ratio | -10,975.06 | -515.45 | 90.05 | -819.93 | -238.46 | -52.00 |
| Asset Turnover | 0.02 | 0.02 | 0.02 | 0.02 | 0.11 | |
| Inventory Turnover | 2.22 | 2.55 | 1.90 | 1.26 | 2.06 | |
| Quick Ratio | 0.20 | 0.20 | 0.23 | 0.25 | 0.25 | 0.26 |
| Current Ratio | 1.06 | 1.10 | 1.14 | 1.18 | 1.25 | 1.36 |
| Return on Equity (ROE) | -2.63% | -5.60% | -6.35% | -9.12% | -1.08% | |
| Return on Assets (ROA) | -0.99% | -1.74% | -2.32% | -2.49% | 0.31% | |
| Return on Invested Capital (ROIC) | -2.16% | -2.06% | -3.68% | -4.99% | -5.30% | 0.67% |
| Return on Capital Employed (ROCE) | -2.20% | -2.10% | -3.40% | -5.10% | -5.40% | 0.60% |
| Earnings Yield | -2.18% | -1.76% | -1.96% | -2.96% | -4.35% | -0.54% |
| FCF Yield | -0.00% | -0.04% | 0.14% | -0.02% | -0.07% | -0.30% |